Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Commercial Officer
-
Stock Symbol
-
GH on Nasdaq
There are no Buy or Sell transactions made by Chris Freeman since 11/23/2023
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Restricted Stock Units |
30.2K |
$712K |
$23.60 |
Nov 8, 2024 |
Direct |
Common Stock |
|
| Common Stock |
31.5K |
$696K |
$22.12 |
Oct 1, 2024 |
Direct |
|
|
| Stock Option (Right to Buy) |
45.2K |
|
|
Nov 8, 2024 |
Direct |
Common Stock |
|
Transactions reported by Chris Freeman for Guardant Health, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.